+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID02097758

Using 3D Transesophageal Echocardiography to Choose Device Size for Closing Atrial Septal Defect without Balloon Sizing

Led by Asan Medical Center · Updated on 2025-02-07

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the use of three-dimensional transesophageal echocardiography to select the correct device size for closing atrial septal defects ASD without using a sizing balloon. The study aims to confirm the accuracy of a previously developed formula for device size prediction and improve the procedure for ASD patients. This research is sponsored by Asan Medical Center and focuses on patients aged 18 to 80 who are candidates for device closure. Participants undergo transcatheter device closure where the device size is chosen using the three-dimensional echocardiographic images combined with the formula, avoiding the use of a sizing balloon. This method is being evaluated for its effectiveness in ensuring successful device implantation during the procedure. During the study, researchers will measure the success of device implantation within one day after the procedure and record procedure time. Participants will be monitored closely to assess outcomes related to the device closure process. The study started in March 2014 and is expected to continue until December 2026, involving adult patients who meet the eligibility criteria.

CONDITIONS

Brief Title

Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Research Team

J

Jong-Min Song, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here